Alumis Inc. Common Stock (ALMS) has 18 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 AyurMaya Capital Management Company, LP 15,139,707 주 보유. 기타 주요 보유자에는 Tananbaum James B. 및 Foresite Labs, LLC.
지난 12개월간 내부자는 66 건의 거래를 수행 ALMS 주식 — 60 건 매수 (평가액 $96.96M) 및 0 건 매도 (평가액 RSU 보상). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.
ALMS 내부자 보유 현황
최대 보유자
AyurMaya Capital Management Company, LP
15,139,707 주
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Ayurmaya Capital Management Company, Lp |
10 Percent Owner, Other: See Remarks |
15,139,707 |
2025-05-23 |
|
| 2 |
Tananbaum James B. |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 3 |
Foresite Labs, Llc |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 4 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 5 |
Akkaraju Srinivas |
Director |
1,853,488 |
2026-01-13 |
|
| 6 |
Babler Martin |
President, CEO and Chairman |
745,875 |
2026-01-28 |
|
| 7 |
Drappa Jorn |
Chief Medical Officer |
221,450 |
2026-01-28 |
|
| 8 |
Schroer John R. |
Chief Financial Officer |
202,225 |
2026-01-28 |
|
| 9 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
190,875 |
2026-01-28 |
|
| 10 |
Bradley Mark Christopher |
Chief Development Officer |
190,225 |
2026-01-28 |
|
| 11 |
Pangali Sanam |
Chief Legal Officer |
186,200 |
2026-01-28 |
|
| 12 |
Yao Zhengbin |
Director |
49,800 |
2025-08-01 |
|
| 13 |
Srivastava Sapna |
Director |
49,800 |
2025-08-01 |
|
| 14 |
Tetrault Lynn A. |
Director |
49,800 |
2025-08-01 |
|
| 15 |
Machado Patrick |
Director |
49,800 |
2025-08-01 |
|
| 16 |
Richardson Derrick |
SVP, People and Culture |
42,800 |
2025-07-31 |
|
| 17 |
Colowick Alan |
Director |
16,104 |
2025-04-03 |
|
| 18 |
Goldstein David M |
Chief Scientific Officer |
8,994 |
2026-02-11 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
기타 (매도) |
1,123,337 |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
기타 (매도) |
1,123,337 |
- |
- |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
기타 (매도) |
1,123,337 |
- |
- |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
알 수 없음 |
- |
- |
- |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
RSU 부여 |
186,200 |
$26.31 |
$4.9M |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
RSU 부여 |
190,225 |
$26.31 |
$5M |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
RSU 부여 |
221,450 |
$26.31 |
$5.83M |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
RSU 부여 |
216,675 |
$26.31 |
$5.7M |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
RSU 부여 |
202,225 |
$26.31 |
$5.32M |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU 부여 |
190,875 |
$26.31 |
$5.02M |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
RSU 부여 |
745,875 |
$26.31 |
$19.62M |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
정보 매수 |
588,235 |
$17.00 |
$10M |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
정보 매수 |
294,117 |
$17.00 |
$5M |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
정보 매수 |
294,117 |
$17.00 |
$5M |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
정보 매수 |
294,117 |
$17.00 |
$5M |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
정보 매수 |
64,969 |
$8.95 |
$581.47K |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
정보 매수 |
66,027 |
$8.18 |
$540.1K |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
정보 매수 |
100,000 |
$7.75 |
$775K |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
정보 매수 |
96,000 |
$7.55 |
$724.8K |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
정보 매수 |
86,350 |
$7.46 |
$644.17K |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
정보 매수 |
38,702 |
$7.64 |
$295.68K |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
정보 매수 |
48,537 |
$7.64 |
$370.82K |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
정보 매수 |
72,212 |
$7.38 |
$532.92K |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
정보 매수 |
72,212 |
$7.38 |
$532.92K |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
정보 매수 |
72,212 |
$7.38 |
$532.92K |